224 related articles for article (PubMed ID: 25916907)
21. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
[TBL] [Abstract][Full Text] [Related]
22. New insights into 3-(aminomethyl)naphthoquinones: Evaluation of cytotoxicity, electrochemical behavior and search for structure-activity correlation.
da Silva GB; Neves AP; Vargas MD; Marinho-Filho JD; Costa-Lotufo LV
Bioorg Med Chem Lett; 2016 Aug; 26(15):3537-42. PubMed ID: 27363939
[TBL] [Abstract][Full Text] [Related]
23. Total synthesis and anticancer activities of (-)- and (+)-thespesone.
Breyer S; Effenberger-Neidnicht K; Schobert R
J Org Chem; 2010 Sep; 75(18):6214-8. PubMed ID: 20712304
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
Shen CC; Afraj SN; Hung CC; Barve BD; Kuo LY; Lin ZH; Ho HO; Kuo YH
Bioorg Med Chem Lett; 2021 Jun; 41():127976. PubMed ID: 33766765
[TBL] [Abstract][Full Text] [Related]
25. Synthetic enamine naphthoquinone derived from lawsone as cytotoxic agents assessed by in vitro and in silico evaluations.
Lemos BC; Westphal R; Filho EV; Fiorot RG; Carneiro JWM; Gomes ACC; Guimarães CJ; de Oliveira FCE; Costa PMS; Pessoa C; Greco SJ
Bioorg Med Chem Lett; 2021 Dec; 53():128419. PubMed ID: 34715305
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and anticancer activity of 2-amidomethoxy-1,4-naphthoquinones and its conjugates with Biotin/polyamine.
Manickam M; Boggu PR; Pillaiyar T; Nam YJ; Abdullah M; Lee SJ; Kang JS; Jung SH
Bioorg Med Chem Lett; 2021 Jan; 31():127685. PubMed ID: 33197549
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
29. A potential antitumor agent, (6-amino-1-methyl-5-nitrosouracilato-N3)-triphenylphosphine-gold(I): structural studies and in vivo biological effects against experimental glioma.
Illán-Cabeza NA; García-García AR; Martínez-Martos JM; Ramírez-Expósito MJ; Peña-Ruiz T; Moreno-Carretero MN
Eur J Med Chem; 2013 Jun; 64():260-72. PubMed ID: 23644209
[TBL] [Abstract][Full Text] [Related]
30. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
[TBL] [Abstract][Full Text] [Related]
31. Biological evaluation of donor-acceptor aminonaphthoquinones as antitumor agents.
Benites J; Valderrama JA; Bettega K; Pedrosa RC; Calderon PB; Verrax J
Eur J Med Chem; 2010 Dec; 45(12):6052-7. PubMed ID: 20980080
[TBL] [Abstract][Full Text] [Related]
32. Target ROS to induce apoptosis and cell cycle arrest by 5,7-dimethoxy-1,4-naphthoquinone derivative.
Li K; Wang B; Zheng L; Yang K; Li Y; Hu M; He D
Bioorg Med Chem Lett; 2018 Feb; 28(3):273-277. PubMed ID: 29305189
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.
Pérez-Sacau E; Díaz-Peñate RG; Estévez-Braun A; Ravelo AG; García-Castellano JM; Pardo L; Campillo M
J Med Chem; 2007 Feb; 50(4):696-706. PubMed ID: 17249647
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and Evaluation of New Naphthalene and Naphthoquinone Derivatives as Anticancer Agents.
Beretta GL; Ribaudo G; Menegazzo I; Supino R; Capranico G; Zunino F; Zagotto G
Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27990691
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of naphthoquinone phenacylimidazolium derivatives.
Yuan J; Liu Z; Zhang Z; Yan D; Zhang W
Bioorg Med Chem Lett; 2021 Jun; 41():127977. PubMed ID: 33766771
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of fused 1,2-naphthoquinones with cytotoxic activity using a one-pot three-step reaction.
Nechaev AA; Jagtap PR; BaŽíková E; Neumannová J; Císařová I; Matoušová E
Org Biomol Chem; 2021 Apr; 19(15):3434-3440. PubMed ID: 33899892
[TBL] [Abstract][Full Text] [Related]
37. Antiproliferative activity of Juglone derivatives on rat glioma.
Pavan V; Ribaudo G; Zorzan M; Redaelli M; Pezzani R; Mucignat-Caretta C; Zagotto G
Nat Prod Res; 2017 Mar; 31(6):632-638. PubMed ID: 27465779
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents.
Wu L; Liu Y; Li Y
Molecules; 2018 Sep; 23(9):. PubMed ID: 30213123
[TBL] [Abstract][Full Text] [Related]
39. Synthetic 1,4-Naphthoquinones inhibit P2X7 receptors in murine neuroblastoma cells.
Pislyagin E; Kozlovskiy S; Menchinskaya E; Chingizova E; Likhatskaya G; Gorpenchenko T; Sabutski Y; Polonik S; Aminin D
Bioorg Med Chem; 2021 Feb; 31():115975. PubMed ID: 33401207
[TBL] [Abstract][Full Text] [Related]
40. N(4)-tolyl-2-acetylpyridine thiosemicarbazones and their platinum(II,IV) and gold(III) complexes: cytotoxicity against human glioma cells and studies on the mode of action.
Ferraz KS; Da Silva JG; Costa FM; Mendes BM; Rodrigues BL; dos Santos RG; Beraldo H
Biometals; 2013 Oct; 26(5):677-91. PubMed ID: 23749148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
